Centene plans to exit the Medicare Advantage (MA) marketplace for 2025 in Alabama, Massachusetts, New Hampshire, New Mexico, Rhode Island, and Vermont. This decision affects Centene’s Wellcare MA line. However, Wellcare will continue to offer Medicare Prescription Drug Plans (PDPs) in these states. The decision does not affect Centene’s Marketplace or Medicaid contracts in these markets.
Wellcare is a wholly owned subsidiary of Centene Corporation, a large health care insurer. For more than 20 years, Wellcare has offered a range of Medicare products, including Medicare Advantage and Medicare PDPs, which offer affordable coverage beyond Original Medicare.
This was reported by Wellcare on August 5, 2024 (accessed August 12, 2024).
Contact information: Wellcare Health Plans, Inc., P.O. Box 31370, Tampa, FL 33631; Website: https://www.wellcare.com/en/contact-us
November 2024 00US24EUA0065